Addressing the targeting range of the ABILHAND-56 in relapsing-remitting multiple sclerosis: A mixed methods psychometric study.
Sophie CleanthousSara StrzokFarrah PompilusStefan CanoPatrick MarquisStanley CohanMyla D GoldmanKiren Kresa-ReahlJennifer PetrilloCarmen Castrillo-VigueraDiego CadavidShih-Yin ChenPublished in: Multiple sclerosis journal - experimental, translational and clinical (2018)
The synthesis of qualitative and quantitative methods used in this study improves the ABILHAND content validity to more effectively identify manual ability changes in early multiple sclerosis and potentially help determine treatment effect in higher-functioning patients in clinical trials.